TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

Stock Futures Rise as Irma Weakens to Tropical Storm and North Korea Is Quiet
FUTURES

Stock Futures Rise as Irma Weakens to Tropical Storm and North Korea Is Quiet

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)
STOCKS

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Peregrine Pharmaceuticals (PPHM) Weak On High Volume Today

What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

Peregrine Pharmaceuticals (PPHM) Stock Gains on Revenue Beat

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG
MARKETS

Peregrine Pharmaceuticals (PPHM) Highlighted As Weak On High Volume

Mobileye Rises After Morgan Stanley, Deutsche Bank Hike Price Targets
INVESTING

Sarepta Soars After Announcing Publication of Ebola Drug Candidate Data

Ambarella Jumps After Analyst Says Buy After Big Selloff
INVESTING

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

AirMedia Group (AMCN) In A Perilous Reversal
MARKETS

Peregrine Pharmaceuticals (PPHM) Marked As A Dead Cat Bounce Stock

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Biotech Stock Mailbag: Exact Sciences, Rexahn, Advaxis, Peregrine

5 Bargain Bin Stocks to Buy in March
INVESTING

2 Biotech Stocks Under $10 to Trade

4 Huge Stocks on Traders' Radars
INVESTING

3 Biotech Stocks Under $10 Making Big Moves

Dating Sites: Best, Worst & Weirdest
MARKETS

Why Peregrine Pharmaceuticals (PPHM) is Surging

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

22 Biotech Stock Predictions for 2014

Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers
OPINION

Consider Buy Rated Stocks Under Five Bucks as Stocking Stuffers

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Four Charts Tear Apart Peregrine Pharma's Quarterly Spin Job

5 Bargain Bin Stocks to Buy in March
INVESTING

5 Stocks Under $10 Set to Soar

Biotech Stock Mailbag: Ziopharm, Oncolytics, Sarepta
STOCKS

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharma

3 Unusual-Volue Stocks on the Rise
INVESTING

5 Under-$10 Stocks Primed to Rise in January

5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More
INVESTING

5 Stocks Poised for Breakouts

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

The Worst Biotech CEO of 2012 Is...

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

Peregrine Shows Desperation in Dusting Off Ancient Brain Tumor Drug

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Your Vote Counts: Who Is the Worst Biotech CEO of 2012?